home / stock / bmy / bmy articles

BMY Articles, Bristol-Myers Squibb Company - From 06/03/24

Stock Information
Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Menu
BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday | Benzinga

Bristol Myers Squibb & Co (NYSE:BMY) announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12 study evaluating Krazati (ada...
FDA Expands Approval For Bristol Myers Squibb's Breyanzi, Making CAR T Cell Therapy Available For Broadest Range Of B-Cell Malignancies | Benzinga

On Thursday, the FDA approved Bristol Myers Squibb Co’s (NYSE:BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric ...

Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare | Benzinga

The mass retirement of the boomer generation has been anticipated as one of the most impactful economic events of the 21st century. Economists are ...

What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday? | Benzinga

Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 t...
Bristol Myers Updates Action Date for Subcutaneous Opdivo | Benzinga

Bristol Myers Squibb (NYSE: BMY) announced that the FDA will now decide on the biologics license application (BLA) for the subcutaneous formulation...

Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retirement Income Security Act of 1974 ("ERISA") (Brower Piven Release) | Benzinga

BALTIMORE, May 23, 2024 (GLOBE NEWSWIRE) -- Lawsuits have been filed alleging that a number of large corporate employers have offloaded billions...

Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M | Benzinga

A judge in Hawaii has reportedly ordered Bristol Myers Squibb & Co (NYSE:BMY) and Sanofi SA (NASDAQ:SNY) to pay the st...
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst | Benzinga

Cantor Fitzgerald has initiated coverage on AbbVie Inc (NYSE:ABBV), a global pharma company. The analyst notes that the company has ...

FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously Treated Follicular Lymphoma | Benzinga

Wednesday, the FDA granted accelerated approval to Bristol Myers Squibb Co’s (NYSE:BMY) Breyanzi (lisocabtagene ...

What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday? | Benzinga

Friday, Aethlon Medical Inc (NASDAQ:AEMD) released results from an in vitro binding study of its Hemopurifier in removing extracellular&n...
Previous 10 Next 10